Thursday, June 28, 2012

U.S. Suffers From Foot Pain

A new survey by Merck, the makers of Dr. Scholl's products revealed last month an astonishing 9 out of 10 Americans have experienced some kind of foot pain, and more than half have missed an activity or event because of that pain. Four out of 10 people believe they would walk more if their feet hurt them less.
"Our 'Dr. Scholl's Get Up & Go' survey found that active lifestyle has Americans with their feet on the ground- more than four hours a day for a third of Americans," said Jim Mackey, senior vice president, US Region Head, Merck Consumer Care. "Our feet are the foundation to living an active, energetic lifestyle, and that's why the essence of the Dr. Scholl's brand is 'Get Up & Go!' We want to help Americans jump into life with both feet, because it all starts from the ground up."
The survey showed that nearly half of Americans do not take the stairs, but choose to ride the elevator instead. 78% prefer to drive to a destination instead of walk.
The Dr. Scholl's survey rated the Top 10 cities where people are on their feet the most. Number one was New York City, number two Boston, and number three Philadelphia.
Those who have desk jobs have said that finding opportunities to walk more has proven difficult. On average, Americans who work in an office still spend about a quarter (23%) of their workday on their feet or walking around. 69% of workers admit they've worn shoes to work that were not part of the dress code, like sneakers, so they would be more comfortable during the day. 58% of women still wear heels on an average of once a week. 86% of women would choose to wear something more comfortable than wear stylish but painful shoes.
If you are experiencing foot pain, especially heel pain, call our Rocky Hill or Middletown office to make an appointment.
Jeffrey S. Kahn, DPM
Connecticut Foot Care Centers
Heel Pain Doctor in CT
Podiatrist in Rocky Hill and Middletown, CT
Visit our website, follow my tweets on Twitter, and friend or like our page on Facebook
Enhanced by Zemanta

No comments:

Post a Comment